<- Go home

Added to YB: 2019-06-19

Pitch date: 2019-06-19

CPRX:US [bullish]

Catalyst Pharmaceuticals, Inc.

+728.68%

current return

Author Info

No bio for this author

Company Info

Catalyst Pharmaceuticals, Inc. operates as a biopharmaceutical company engaged in developing and commercializing novel medicines for patients living with rare diseases.

Market Cap

$3.9B

Pitch Price

$3.80

Price Target

N/A

Dividend

N/A

EV/EBITDA

10.13

P/E

18.20

EV/Sales

5.20

Sector

Biotechnology

Category

N/A

Show full summary:
Catalyst Pharmaceuticals, Inc. CPRX:US

A summary for this pitch has not been created yet.

Read full article (0 min)